ArticleThe American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry2026
Association Between State Essential Caregiver Programs and Antipsychotic Medication Use Rate in Nursing Homes During the COVID-19 Pandemic.
Article in The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
Abstract
objectivesThis study aims to assess the association between Essential Caregiver Programs (ECPs) implementation and antipsychotic use among nursing home residents.
methodsWe conducted a difference-in-differences analysis using quarterly data from 2018 to 2022 for Medicare- and/or Medicaid-certified nursing homes across the United States. The primary outcomes were (1) the percentage of long-stay residents receiving antipsychotic medications and (2) the percentage of short-stay residents newly prescribed antipsychotics. Models included nursing home and county covariates, state and time fixed effects, and facility-level random effects.
resultsUnadjusted analyses indicated that nursing homes in ECP states had higher baseline rates of antipsychotic use before program implementation compared to other states, but experienced larger reductions in rates after program implementation. Adjusted DID analyses showed no significant ECP-associated changes in antipsychotic use during the first 4 quarters following ECP implementation; however, significant reductions emerged after 4 quarters among long-stay residents (coef. = -0.260 percentage points; 95% CI: -0.355 to -0.164; p <0.01) and short-stay residents (coef. = -0.062 percentage points; 95% CI: -0.104 to -0.020; p <0.01). Stratified analyses indicated that ECP-associated reductions are mainly observed in for-profit nursing homes and nursing homes with lower quality ratings. DISCUSSION: One year after program implementation, state ECPs were associated with reduced antipsychotic use among nursing home residents, particularly in for-profit and lower-rated facilities. These findings highlight the importance of caregiver involvement to improve medication practices and resident well-being. Policies should aim to balance infection control with the therapeutic benefits of caregiver presence in nursing homes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.